The findings add to a growing body of evidence that treatment de-escalation is feasible and safe for favorable-risk early ...

HealthDay News — A three-month supervised resistance training regimen yields meaningful functional gains in patients with breast cancer, regardless of surgical management of the breast and axilla, ...

Neoadjuvant Enhertu→THP improved pCR to 67.3% vs 56.3% with AC→THP in stage II–III high-risk HER2-positive disease (DESTINY-Breast11). Adjuvant Enhertu achieved 3-year IDFS 92.4% vs 83.7% with T-DM1 ...

Breast cancer management has undergone a remarkable transformation over the past few decades. From radical, disfiguring surgeries to highly refined, patient-centered approaches, modern oncology now ...

The first question that most breast cancer patients ask is whether they will need chemotherapy. Their eyes are filled with ...

II block is widely used for perioperative analgesia in breast surgery. We describe a case of transient upper limb weakness ...